Close Menu

GeneProt Paid Waters $7.7M in Termination Fees

In its recently released 10-Q report for the quarter ended September 30, 2002, Waters said that in connection with GeneProt’s canceled order of up to $20 million in mass spectrometry equipment, related systems, and services, Waters received approximately $7.7 million from GeneProt as a termination fee. The company collected $2.5 million of this in June of this year. The remainder was a customer advance that Waters received in December 2001.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.